vs

Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and DigitalBridge Group, Inc. (DBRG). Click either name above to swap in a different company.

DigitalBridge Group, Inc. is the larger business by last-quarter revenue ($105.7M vs $77.6M, roughly 1.4× Bioceres Crop Solutions Corp.). DigitalBridge Group, Inc. runs the higher net margin — 61.5% vs -9.6%, a 71.1% gap on every dollar of revenue. On growth, DigitalBridge Group, Inc. posted the faster year-over-year revenue change (4.1% vs -16.8%). Over the past eight quarters, DigitalBridge Group, Inc.'s revenue compounded faster (19.2% CAGR vs -8.4%).

Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.

DigitalBridge Group, Inc. is a global digital infrastructure investment firm. The company owns, invests in and operates businesses such as cell towers, data centers, fiber, small cells, and edge infrastructure. Headquartered in Boca Raton, DigitalBridge has offices in Los Angeles, New York, Denver, London, and Singapore. As of June 2025, DigitalBridge had US$106 billion of assets under management.

BIOX vs DBRG — Head-to-Head

Bigger by revenue
DBRG
DBRG
1.4× larger
DBRG
$105.7M
$77.6M
BIOX
Growing faster (revenue YoY)
DBRG
DBRG
+21.0% gap
DBRG
4.1%
-16.8%
BIOX
Higher net margin
DBRG
DBRG
71.1% more per $
DBRG
61.5%
-9.6%
BIOX
Faster 2-yr revenue CAGR
DBRG
DBRG
Annualised
DBRG
19.2%
-8.4%
BIOX

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BIOX
BIOX
DBRG
DBRG
Revenue
$77.6M
$105.7M
Net Profit
$-7.4M
$65.1M
Gross Margin
46.8%
Operating Margin
9.3%
Net Margin
-9.6%
61.5%
Revenue YoY
-16.8%
4.1%
Net Profit YoY
-20.2%
EPS (diluted)
$-0.12
$0.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIOX
BIOX
DBRG
DBRG
Q4 25
$105.7M
Q3 25
$77.6M
$93.3M
Q2 25
$85.3M
Q1 25
$60.6M
$90.1M
Q4 24
$98.8M
$101.6M
Q3 24
$93.3M
$76.6M
Q2 24
$390.3M
Q1 24
$84.0M
$74.4M
Net Profit
BIOX
BIOX
DBRG
DBRG
Q4 25
$65.1M
Q3 25
$-7.4M
$31.4M
Q2 25
$31.6M
Q1 25
$-1.6M
$13.8M
Q4 24
$605.2K
Q3 24
$-6.2M
$13.8M
Q2 24
$91.4M
Q1 24
$9.8M
$-29.6M
Gross Margin
BIOX
BIOX
DBRG
DBRG
Q4 25
Q3 25
46.8%
Q2 25
Q1 25
39.4%
Q4 24
42.0%
Q3 24
40.2%
Q2 24
Q1 24
50.8%
Operating Margin
BIOX
BIOX
DBRG
DBRG
Q4 25
Q3 25
9.3%
-13.9%
Q2 25
-31.2%
Q1 25
1.5%
-11.5%
Q4 24
14.5%
5.7%
Q3 24
2.5%
62.4%
Q2 24
33.5%
Q1 24
15.7%
-20.7%
Net Margin
BIOX
BIOX
DBRG
DBRG
Q4 25
61.5%
Q3 25
-9.6%
33.7%
Q2 25
37.1%
Q1 25
-2.6%
15.3%
Q4 24
0.6%
Q3 24
-6.6%
18.0%
Q2 24
23.4%
Q1 24
11.6%
-39.8%
EPS (diluted)
BIOX
BIOX
DBRG
DBRG
Q4 25
$0.28
Q3 25
$-0.12
$0.09
Q2 25
$0.10
Q1 25
$-0.02
$-0.01
Q4 24
$0.00
Q3 24
$-0.10
$-0.01
Q2 24
$0.44
Q1 24
$0.14
$-0.28

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIOX
BIOX
DBRG
DBRG
Cash + ST InvestmentsLiquidity on hand
$15.5M
$382.5M
Total DebtLower is stronger
$298.8M
Stockholders' EquityBook value
$288.3M
$2.1B
Total Assets
$734.9M
$3.4B
Debt / EquityLower = less leverage
0.14×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIOX
BIOX
DBRG
DBRG
Q4 25
$382.5M
Q3 25
$15.5M
$358.4M
Q2 25
$340.7M
Q1 25
$38.5M
$349.9M
Q4 24
$29.2M
$302.2M
Q3 24
$32.3M
$294.4M
Q2 24
$261.2M
Q1 24
$16.4M
$247.4M
Total Debt
BIOX
BIOX
DBRG
DBRG
Q4 25
$298.8M
Q3 25
$327.9M
Q2 25
$298.0M
Q1 25
$296.9M
Q4 24
$296.4M
Q3 24
$295.8M
Q2 24
$295.3M
Q1 24
$366.5M
Stockholders' Equity
BIOX
BIOX
DBRG
DBRG
Q4 25
$2.1B
Q3 25
$288.3M
$2.1B
Q2 25
$2.0B
Q1 25
$345.0M
$2.0B
Q4 24
$346.3M
$2.0B
Q3 24
$346.0M
$2.0B
Q2 24
$2.0B
Q1 24
$348.5M
$1.8B
Total Assets
BIOX
BIOX
DBRG
DBRG
Q4 25
$3.4B
Q3 25
$734.9M
$3.5B
Q2 25
$3.4B
Q1 25
$798.2M
$3.4B
Q4 24
$835.2M
$3.5B
Q3 24
$827.3M
$3.5B
Q2 24
$3.5B
Q1 24
$836.1M
$3.5B
Debt / Equity
BIOX
BIOX
DBRG
DBRG
Q4 25
0.14×
Q3 25
0.16×
Q2 25
0.15×
Q1 25
0.15×
Q4 24
0.15×
Q3 24
0.15×
Q2 24
0.15×
Q1 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIOX
BIOX
DBRG
DBRG
Operating Cash FlowLast quarter
$14.4M
$259.3M
Free Cash FlowOCF − Capex
$258.0M
FCF MarginFCF / Revenue
244.0%
Capex IntensityCapex / Revenue
1.3%
Cash ConversionOCF / Net Profit
3.99×
TTM Free Cash FlowTrailing 4 quarters
$440.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIOX
BIOX
DBRG
DBRG
Q4 25
$259.3M
Q3 25
$14.4M
$56.5M
Q2 25
$77.0M
Q1 25
$23.3M
$50.3M
Q4 24
$-5.4M
$60.1M
Q3 24
$5.2M
$35.9M
Q2 24
$22.5M
Q1 24
$-17.4M
$-27.0M
Free Cash Flow
BIOX
BIOX
DBRG
DBRG
Q4 25
$258.0M
Q3 25
$56.1M
Q2 25
$76.4M
Q1 25
$50.0M
Q4 24
$56.5M
Q3 24
Q2 24
$22.3M
Q1 24
$-30.1M
FCF Margin
BIOX
BIOX
DBRG
DBRG
Q4 25
244.0%
Q3 25
60.2%
Q2 25
89.5%
Q1 25
55.5%
Q4 24
55.7%
Q3 24
Q2 24
5.7%
Q1 24
-40.4%
Capex Intensity
BIOX
BIOX
DBRG
DBRG
Q4 25
1.3%
Q3 25
0.4%
Q2 25
0.7%
Q1 25
0.3%
Q4 24
3.5%
Q3 24
0.0%
Q2 24
0.1%
Q1 24
4.1%
Cash Conversion
BIOX
BIOX
DBRG
DBRG
Q4 25
3.99×
Q3 25
1.80×
Q2 25
2.43×
Q1 25
3.65×
Q4 24
-8.85×
Q3 24
2.61×
Q2 24
0.25×
Q1 24
-1.78×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons